253 related articles for article (PubMed ID: 18372913)
1. Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion.
Arora P; Cuevas BD; Russo A; Johnson GL; Trejo J
Oncogene; 2008 Jul; 27(32):4434-45. PubMed ID: 18372913
[TBL] [Abstract][Full Text] [Related]
2. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
3. Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion.
Booden MA; Eckert LB; Der CJ; Trejo J
Mol Cell Biol; 2004 Mar; 24(5):1990-9. PubMed ID: 14966279
[TBL] [Abstract][Full Text] [Related]
4. The α-arrestin ARRDC3 suppresses breast carcinoma invasion by regulating G protein-coupled receptor lysosomal sorting and signaling.
Arakaki AKS; Pan WA; Lin H; Trejo J
J Biol Chem; 2018 Mar; 293(9):3350-3362. PubMed ID: 29348172
[TBL] [Abstract][Full Text] [Related]
5. The activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion.
Fujimoto D; Hirono Y; Goi T; Katayama K; Matsukawa S; Yamaguchi A
BMC Cancer; 2010 Aug; 10():443. PubMed ID: 20723226
[TBL] [Abstract][Full Text] [Related]
6. Thrombin stimulation of inflammatory breast cancer cells leads to aggressiveness via the EGFR-PAR1-Pak1 pathway.
Ohshiro K; Bui-Nguyen TM; Divijendra Natha RS; Schwartz AM; Levine P; Kumar R
Int J Biol Markers; 2012 Dec; 27(4):e305-13. PubMed ID: 23280128
[TBL] [Abstract][Full Text] [Related]
7. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.
Boire A; Covic L; Agarwal A; Jacques S; Sherifi S; Kuliopulos A
Cell; 2005 Feb; 120(3):303-13. PubMed ID: 15707890
[TBL] [Abstract][Full Text] [Related]
8. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation.
Darmoul D; Gratio V; Devaud H; Peiretti F; Laburthe M
Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630
[TBL] [Abstract][Full Text] [Related]
9. Plasma kallikrein promotes epidermal growth factor receptor transactivation and signaling in vascular smooth muscle through direct activation of protease-activated receptors.
Abdallah RT; Keum JS; El-Shewy HM; Lee MH; Wang B; Gooz M; Luttrell DK; Luttrell LM; Jaffa AA
J Biol Chem; 2010 Nov; 285(45):35206-15. PubMed ID: 20826789
[TBL] [Abstract][Full Text] [Related]
10. β-adrenergic receptor stimulation transactivates protease-activated receptor 1 via matrix metalloproteinase 13 in cardiac cells.
Jaffré F; Friedman AE; Hu Z; Mackman N; Blaxall BC
Circulation; 2012 Jun; 125(24):2993-3003. PubMed ID: 22610965
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated protease activated receptor 1 (PAR1) promotes metastatic phenotype in breast cancer through HMGA2.
Yang E; Cisowski J; Nguyen N; O'Callaghan K; Xu J; Agarwal A; Kuliopulos A; Covic L
Oncogene; 2016 Mar; 35(12):1529-40. PubMed ID: 26165842
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro.
Ma C; Lin H; Leonard SS; Shi X; Ye J; Luo J
Oncogene; 2003 Aug; 22(34):5281-90. PubMed ID: 12917629
[TBL] [Abstract][Full Text] [Related]
13. Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells.
Kamath L; Meydani A; Foss F; Kuliopulos A
Cancer Res; 2001 Aug; 61(15):5933-40. PubMed ID: 11479236
[TBL] [Abstract][Full Text] [Related]
14. Targeting Gi/o protein-coupled receptor signaling blocks HER2-induced breast cancer development and enhances HER2-targeted therapy.
Lyu C; Ye Y; Lensing MM; Wagner KU; Weigel RJ; Chen S
JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34343132
[TBL] [Abstract][Full Text] [Related]
15. PAR-type thrombin receptors in renal carcinoma cells: PAR1-mediated EGFR activation promotes cell migration.
Bergmann S; Junker K; Henklein P; Hollenberg MD; Settmacher U; Kaufmann R
Oncol Rep; 2006 Apr; 15(4):889-93. PubMed ID: 16525676
[TBL] [Abstract][Full Text] [Related]
16. N-linked glycosylation of protease-activated receptor-1 at extracellular loop 2 regulates G-protein signaling bias.
Soto AG; Smith TH; Chen B; Bhattacharya S; Cordova IC; Kenakin T; Vaidehi N; Trejo J
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3600-8. PubMed ID: 26100877
[TBL] [Abstract][Full Text] [Related]
17. Regulator of G protein signaling 8 inhibits protease-activated receptor 1/Gi/o signaling by forming a distinct G protein-dependent complex in live cells.
Lee J; Ghil S
Cell Signal; 2016 May; 28(5):391-400. PubMed ID: 26829215
[TBL] [Abstract][Full Text] [Related]
18. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
[TBL] [Abstract][Full Text] [Related]
19. Human protease-activated receptor 1 expression in malignant epithelia: a role in invasiveness.
Yin YJ; Salah Z; Grisaru-Granovsky S; Cohen I; Even-Ram SC; Maoz M; Uziely B; Peretz T; Bar-Shavit R
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):940-4. PubMed ID: 12637343
[TBL] [Abstract][Full Text] [Related]
20. ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors.
Ohtsu H; Dempsey PJ; Eguchi S
Am J Physiol Cell Physiol; 2006 Jul; 291(1):C1-10. PubMed ID: 16769815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
